Cancer clinical trials in the region Bretagne

146 currently recruiting clinical trials
Region Bretagne

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Breast cancer
#NCT06760637
HER2 Negative HR Positive Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Eugene Marquis (Rennes)
Pfizer
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT06319820
Non-invasive bladder cancer Localized FGFR None 1 2 3 or more
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Janssen
Phase 3 Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Genmab
Phase 3 Stomach and esophageal cancer
#NCT06346392
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic Claudin 18.2 1 2 3 or more Chemotherapy
HER2 Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
AstraZeneca